However, IL-1β levels were not significantly altered by ML385 treatment, and the reduction in ROS levels observed with Lupeol/7KCh co-treatment did not reach statistical significance when ML385 was added, highlighting the complexity of this regulatory axis.
← all excerpts
Lupeol Attenuates Oxysterol-Induced Dendritic Cell Activation Through NRF2-Mediated Antioxidant and Anti-Inflammatory Effects.
1
—
—